Kuehn Law, PLLC is investigating whether certain officers and directors of Globus Medical, Inc. breached their fiduciary duties by engaging in potential self-dealing. This legal inquiry could lead to damages for shareholders and reforms in corporate governance. Long-term shareholders of Globus Medical are encouraged to contact the law firm to protect their rights, as there may be limited time to act. The investigation highlights concerns about management's responsibility to act in shareholders' best interests.
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
CASHCAT cryptocurrency remains under strong selling pressure, unable to recover past key resistance levels between $0.125 and $0.133. The token has stabilized near $0.10 but continues to show a bearish trend with lower highs and lows since its peak a...
Cronos (CRO) surged 7.43% to $0.0597, leading gains among altcoins due to strategic partnerships and ecosystem growth. Other notable gainers included Beldex, Stable, Mantle, and Polkadot, each rising between 2% and 6%. Conversely, Lighter fell 10.43%...
Large Ethereum purchases by whales, including Arthur Hayes buying 1,293 ETH and a 21.3K ETH transfer from Fidelity Custody to a new wallet, highlight growing institutional confidence despite ETH trading below $2,000. Exchange data shows mixed short-t...
